Can Vaginal PRP Injections Revitalize Sexual Function?

Can Vaginal PRP Injections Revitalize Sexual Function?

Recent clinical evidence highlights the benefits of Vaginal PRP injections for improving female sexual health. Specifically, a new randomized trial explored how this therapy aids premenopausal women. Doctors often seek safe, effective ways to enhance patient quality of life. Therefore, this study provides a crucial data point for regenerative medicine in gynecology.

Clinical Outcomes of Vaginal PRP Injections

Researchers randomized fifty-two participants to receive either a PRP injection or a saline placebo. They focused on women between 18 and 50 years old without severe dysfunction. Consequently, the team followed these patients for six months to track changes. Their primary goal involved assessing the Female Sexual Function Index (FSFI) score at the six-week mark.

The results showed that women receiving PRP experienced a significant increase in their FSFI scores. For example, the median score rose more in the treatment group than in the control group. Furthermore, this improvement remained visible throughout the six-month study period. Interestingly, the treatment group also reported higher satisfaction via global improvement scales. Indeed, nearly 70% of the PRP group noticed positive changes.

Safety remains a top priority for any clinical procedure. Fortunately, the trial reported no serious adverse events among the participants. This finding suggests that the treatment is well-tolerated by healthy premenopausal women. Moreover, practitioners should note that the injections targeted the distal anterior vaginal wall. While specific subscale improvements like arousal and orgasm occurred, they lacked statistical significance compared to the placebo. However, the overall trend supports the efficacy of the procedure.

Frequently Asked Questions

Q1: What were the primary benefits of vaginal PRP injections seen in this study?

The primary benefit was a significant increase in the total Female Sexual Function Index (FSFI) score at six weeks and six months compared to the placebo group.

Q2: Is the procedure safe for premenopausal women?

Yes, researchers reported no serious adverse events during the six-month trial, indicating a strong safety profile for this specific injection technique.

Q3: How long do the improvements from the treatment last?

The study demonstrated that improvements in sexual satisfaction and function remained evident for at least six months following the single injection.

References

1. Clarke B et al. Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A Randomized Controlled Trial. Obstet Gynecol. 2026 May 01. doi: 10.1097/AOG.0000000000006256. PMID: 41855531.
2. Dawood AS, Salem HA. Current status of platelet-rich plasma (PRP) in gynecology. Middle East Fertil Soc J. 2018;23(1):1-9.
3. Kim SH, et al. The efficacy of platelet-rich plasma for female sexual dysfunction: A systematic review and meta-analysis. J Pers Med. 2020;10(4):255.